DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal

Area of Science:

• Pharmacology
• Bioinformatics
• Computational Biology

Background:

• Combinatorial therapies show promise for complex diseases by targeting multiple pathways.
• DrugComb is a web portal for drug combination screening data analysis.
• Previous versions focused on data deposition and analysis of drug combinations.

Purpose of the Study:

• To report significant updates to the DrugComb web portal.
• To enhance data coverage, analysis tools, and predictive capabilities for drug combinations.
• To provide a comprehensive resource for studying drug sensitivities across multiple diseases.

Main Methods:

• Manual curation and harmonization of extensive drug combination and monotherapy screening data.
• Development of enhanced algorithms for assessing drug sensitivity and synergy.
• Implementation of network modeling tools for visualizing drug mechanisms of action.
• Integration of machine learning models for predicting drug combination outcomes.

Main Results:

• Expanded data coverage to include cancers, malaria, and COVID-19.
• Improved algorithms for sensitivity and synergy assessment.
• New network modeling and machine learning tools for mechanism visualization and prediction.
• Enhanced user interface and database infrastructure for faster access and analysis.

Conclusions:

• DrugComb is now the most comprehensive web resource for drug combination studies.
• The updates facilitate improved analysis, visualization, and interpretation of drug screening data.
• The platform supports research into combinatorial therapies for a wider range of diseases.